Anti-AQP4 Titer Is Not Predictive of Disease Course in Neuromyelitis Optica Spectrum Disorder

被引：0
|
作者：
Kessler, Remi A.
Mealy, Maureen A.
Levy, Michael
机构：
来源：
ANNALS OF NEUROLOGY | 2016年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
M103
引用
收藏
页码：S147 / S148
页数：2
相关论文
共 50 条
  • [41] Neuromyelitis optic with positive Anti-AQP4 and Anti-SSA/Ro antibody
    Estiasari, Riwanti
    Firdausia, Salsahila
    Wulandari, Dewi
    Maharani, Kartika
    Sitorus, Freddy
    Pangeran, David
    Imran, Darma
    NEUROLOGY INTERNATIONAL, 2019, 11 (01) : 1 - 3
  • [42] A western blot and immunoprecipitation method to detect anti-NMO IgG and anti-AQP4 antibodies in the serum of patients with neuromyelitis optica
    Bertalotto, Antonio
    Marnetto, Fabiana
    Hellias, Bianca
    Valentino, Paola
    Capobianco, Marco
    Malucchi, Simona
    Di Sapio, Alessia
    Granieri, Letizia
    Caldano, Marzia
    Gilli, Francesca
    Sala, Arianna
    NEUROLOGY, 2008, 70 (11) : A267 - A267
  • [43] Late onset neuromyelitis optica spectrum disorders (LONMOSD) from a nationwide Portuguese study: Anti-AQP4 positive, anti-MOG positive and seronegative subgroups
    Santos, Ernestina
    Moura, Joao
    Samoes, Raquel
    Paula Sousa, Ana
    Mendonca, Teresa
    Abreu, Pedro
    Guimaraes, Joana
    Correia, Ines
    Duraes, Joao
    Sousa, Livia
    Ferreira, Joao
    de Sa, Joao
    Sousa, Filipa
    Sequeira, Marta
    Sofia Correia, Ana
    Luisa Andre, Ana
    Basilio, Carlos
    Arenga, Marta
    Bras Marques, Ines
    Perdigao, Sandra
    Alves, Ivania
    Santos, Mariana
    Salgado, Vasco
    Palos, Adelaide
    Guerreiro, Rui
    Isidoro, Luis
    Boleixa, Daniela
    Carneiro, Paula
    Neves, Esmeralda
    Martins Silva, Ana
    Goncalves, Guilherme
    Sa, Maria Jose
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 63
  • [44] Aquaporin-4-neuromyelitis optica spectrum disorder is not a progressive disease
    Villoslada, Pablo
    Sanchez-Dalmau, Bernardo
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (02): : 116 - 117
  • [45] Neuromyelitis Optica with NMO-IgG/Anti-AQP4 Antibody Positive: First Case Reported from Uttarakhand India
    Mittal, Manish
    Mittal, Garima
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2014, 8 (07) : MD3 - MD4
  • [46] Clinical course of neuromyelitis optica spectrum disorder in a moroccan cohort
    Bennis, Anas
    El Otmani, Hicham
    Benkirane, Nada
    Harrizi, Ilham
    El Moutawakil, Bouchra
    Abdoh Rafai, Mohammed
    Slassi, Ilham
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 30 : 141 - 148
  • [47] Endocrinopathies in paediatric-onset neuromyelitis optica spectrum disorder with aquaporin 4 (AQP4) antibody
    Hacohen, Yael
    Messina, Silvia
    Gan, Hoong-Wei
    Wright, Sukhvir
    Chandratre, Saleel
    Leite, Maria Isabel
    Fallon, Penny
    Vincent, Angela
    Ciccarelli, Olga
    Wassmer, Evangeline
    Lim, Ming
    Palace, Jacqueline
    Hemingway, Cheryl
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (05) : 679 - 684
  • [48] Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder
    Akaishi, Tetsuya
    Takahashi, Toshiyuki
    Misu, Tatsuro
    Kaneko, Kimihiko
    Takai, Yoshiki
    Nishiyama, Shuhei
    Ogawa, Ryo
    Fujimori, Juichi
    Ishii, Tadashi
    Aoki, Masashi
    Fujihara, Kazuo
    Nakashima, Ichiro
    NEUROLOGY, 2021, 97 (01) : E1 - E12
  • [49] Unique characteristics of AQP4-specific T cells in patients with AQP4+neuromyelitis optica spectrum disorder (NMOSD)
    Saggau, C.
    Bacher, P.
    Esser, D.
    Leypoldt, F.
    Wandinger, K. -P.
    Paul, F.
    Martin, R.
    Fillatreau, S.
    Schober, K.
    Busch, D.
    Stuerner, K.
    Dargvainiene, J.
    Scheffold, A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 271 - 272
  • [50] A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course
    Solomon, Jacqueline M.
    Paul, Friedemann
    Chien, Claudia
    Oh, Jiwon
    Rotstein, Dalia L.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
12345